Cantor Fitzgerald’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-94,584
| Closed | -$10.6M | – | 437 |
|
|
2023
Q3 | $10.6M | Sell |
94,584
-750
| -0.8% | -$84.4K | 0.28% | 123 |
|
|
2023
Q2 | $8.99M | Sell |
95,334
-120
| -0.1% | -$11.3K | 0.21% | 156 |
|
|
2023
Q1 | $9.66M | Sell |
95,454
-4,651
| -5% | -$471K | 0.21% | 169 |
|
|
2022
Q4 | $12M | Buy |
100,105
+6,825
| +7% | +$815K | 0.26% | 136 |
|
|
2022
Q3 | $9.91M | Buy |
+93,280
| New | +$9.91M | 0.22% | 150 |
|